Betalin Therapeutics For Profit

Betalin is a company developing a micro-pancreas to help diabetic patients liberate from their daily insulin dependency. The company uses a combination of stem cell technology and tissue engineering to create a fully functional engineered micro-pancreas that can supply daily insulin replacement. The micro-pancreas responds to the patient's blood glucose levels by releasing regulated therapeutic levels of insulin. The company aims to provide a long-term solution for the management of diabetes. The company has a team of scientists, engineers, clinical experts, and an advisory board. Contact info: +972-2-992-2025, info@betalintherapeutics.com, Jerusalem Bio Park (JBP), Minrav Bldg, 1st Floor, Hadassah Ein Keren Campus, Jerusalem, Israel.

Founded Date: 2015-07-01
Headquarters: Ramat Gan, Tel Aviv, Israel
Technology: Stem cells
Employee Number: 1-10
Industry: Regenerative Medicine
Estimated Revenue: $1.4Mper year
Number Of Exists: N/A
Funding Status: Early Stage Venture
Investor Type: N/A
Investment Stage: N/A